Endocrine Society Part of Coalition That Developed New Osteoporosis, Fracture Treatment Guidelines

  • Oct 2019

The Endocrine Society recently participated in a coalition of bone health experts, physicians, specialists, and patient advocacy groups to develop clinical care recommendations for the treatment of osteoporosis and resulting hip and spine fractures.

The Secondary Fracture Prevention: Consensus Recommendations from a Multistakeholder Coalition was published online in the peer-reviewed Journal of Bone and Mineral Research.

These recommendations outline the best course of clinical care for women and men, ages 65 years or older, with a hip or vertebral fracture, and emphasize that fracture patients should be managed in a multi-disciplinary clinical system to ensure appropriate evaluation and treatment for osteoporosis and risk of future fractures.

You may also like

  • High Time: Addressing Research Gaps in Opioid-Associated Endocrine Conditions

    By Derek Bagley

    Endocrine News speaks with Niki Karavitaki, MSc, PhD, FRCP, of the University of Birmingham, Birmingham Health Partners, and the University Hospitals Birmingham National Health Service Foundation Trust in Birmingham, U.K., chair of the Endocrine Society’s recent Scientific Statement on opioids’ impact on the endocrine system. She discusses gaps in research, as well as why healthcare…

  • Endocrine Society Scientific Statement Reviews Research on Opioids’ Effect on Bone, Adrenal Health 

    A new Scientific Statement released by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.  The use and misuse of opioids are a growing global problem. Opioids are used to treat pain in people with cancer or other conditions (e.g., after an injury or surgery), however,…

Find more in